Mark Socinski News Today

Top coverage from the National Association of Managed Care Physicians (NAMCP) Spring Managed Care Forum 2023 included sessions on value-based care implementation and best treatment practices.

Experts emphasize the crucial role of swift diagnostic testing, especially through liquid biopsies.

Panelists share their final thoughts on staying updated with the latest advancements in the field.

Specialists delve into strategies for monitoring treatment response and the importance of assessing symptoms during the initial three treatment cycles.

Experts address the impact of platinum shortages, 4-cycle platinum chemotherapy, and available treatments beyond platinum chemotherapy.

Providers speak to the importance of encouraging patients to self-report adverse reactions and participate in shared decision making.

A conversation on patient tolerance of CTLA-4 immunotherapies, alongside an exploration of treatment-related adverse reactions is discussed by a panel of experts.

Specialists engage in a conversation regarding the treatment duration and the effectiveness of the current two-year approach.

Specialists evaluate their clinical strategies for managing second-line driver-negative and initial PD-L1 negative patients.

Specialists address the intricate factors between comorbidities, efficacy, and tolerance, which influence their treatment approaches at the time of diagnosis.